Orasis Pharmaceuticals

Last updated: October 11, 2024

Elad Kedar, CEO
Elad Kedar, CEO
Israel | Funding: $126M (+)

Website: https://www.orasis-pharma.com/

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.